Pharmacy benefit managers report that brand-name semaglutide medications currently cost approximately $200 to $400 per month in Canada, with the variation attributed to: Prescribed dosage strength Regional pharmacy markup policies Provincial drug pricing regulations Wholesale distribution agreements Generic Competition Timeline Impact The current pricing landscape comes as Health Canada continues reviewing nine generic semaglutide applications following the January 2026 patent expiration
2.2.1 TGF- TGF- is the most potent pro-fibrotic mediator, inducing ECM, EMT, and pro-fibrotic mediators production by promoting the binding of Smad2/3 to Smad4, and driving myofibroblast differentiation to promote the PF process (Hu et al., 2018
[9] [10] For patients with established cardiovascular disease, SGLT2 inhibitors are generally prioritised for cardiorenal protection, with GLP-1 receptor agonists with proven cardiovascular benefit considered when SGLT2 inhibitors are unsuitable
GLP-1 medications are a modern, evidence-based approach to weight management that work by regulating appetite, improving satiety, and helping patients reduce overall caloric intake without extreme dieting or unsafe stimulant use
At the end of the experiment, mice were anesthetized with 1% sodium pentobarbital (60 mg/kg) intraperitoneal injection
Supplementary material The Supplementary Material for this article can be found online at: References Adachi S., Kawamoto T., Otsuka M., Todoroki T., Fukao K
